Peng Xiu - Concepedia

Author

Peng Xiu

Shandong Provincial QianFoShan Hospital ORCID

Also Known As

P. Xiu, PENG XIU, Peng Xiu, Xiu, Peng

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Shandong Provincial QianFoShan Hospital Shandong University The People's Hospital of Guangxi Zhuang Autonomous Region First Affiliated Hospital of Harbin Medical University Harbin Medical University

About

Peng Xiu is an author at Shandong Provincial QianFoShan Hospital specializing in medicine, tumor biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	459
2	Cell Biology	6	6	404
3	Health Sciences	3	3	249
4	Engineering	1	1	18
5	Computer Science	1	1	18

Peng Xiu

Publications

913

Citations

H-Index

Page 1

	Year	Citations
Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the <scp>YAP</scp>‐<scp>TEAD</scp> complex Honglong Wei, Fuhai Wang, Yong Wang, Cancer Science PathologyCell DeathCancer BiologyPdac CellsTumor Biology	2016	206
circ-BIRC6, a circular RNA, promotes hepatocellular carcinoma progression by targeting the miR-3918/Bcl2 axis Guangsheng Yang, Xin Wang, Bingqi Liu, Cell Cycle ImmunologyPathologyHepatocellular Carcinoma ProgressionMir-3918/bcl2 AxisTumor Biology	2019	73
The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma Wentao Wang, Yaxun Guo, Jingtao Zhong, Scientific Reports	2021	70
Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma Peng Xiu, Xuesong Dong, Xiaofeng Dong, Cancer Science ApoptosisCell DeathCancer BiologyTumor BiologyOxidative Stress	2012	61
Vitamin A Supplementation Alleviates Extrahepatic Cholestasis Liver Injury through Nrf2 Activation Guiyang Wang, Peng Xiu, Fu Li, Oxidative Medicine and Cellular Longevity	2014	48
Meloxicam Executes Its Antitumor Effects against Hepatocellular Carcinoma in COX-2- Dependent and -Independent Pathways Xiaofeng Dong, Rui Li, Peng Xiu, PLoS ONE	2014	46
Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC Qingbin Liu, Xiangyu Zhang, Jingjing Qi, Hepatology	2024	44
Secretory Clusterin Mediates Oxaliplatin Resistance via the Gadd45a/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma Xin Wang, Fang Zou, Jingtao Zhong, Journal of Cancer	2018	40
Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway Tao Li, Jingtao Zhong, Xiaofeng Dong, Oncology Reports	2016	35
Targeting hypoxia-inducible factor-2α enhances sorafenib antitumor activity via β-catenin/C-Myc-dependent pathways in hepatocellular carcinoma Feng Liu, Xiaofeng Dong, Hong Lv, Oncology Letters PathologyCancer BiologyTumor Biologyβ-Catenin/c-myc-dependent PathwaysCancer Cell Biology	2015	34

Page 1